Source:http://linkedlifedata.com/resource/pubmed/id/17378899
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006034,
umls-concept:C0011306,
umls-concept:C0030685,
umls-concept:C0033268,
umls-concept:C0039194,
umls-concept:C0262950,
umls-concept:C0384648,
umls-concept:C0391871,
umls-concept:C0439858,
umls-concept:C0680255,
umls-concept:C0963088,
umls-concept:C1283071,
umls-concept:C1514873,
umls-concept:C1515877,
umls-concept:C1546857,
umls-concept:C1556066,
umls-concept:C1619636,
umls-concept:C1879547,
umls-concept:C1963578
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-23
|
pubmed:abstractText |
Lyme borreliosis is characterized by cellular inflammatory responses at multiple body sites. Recently, an association of interleukin-17 (IL-17) and Lyme arthritis was suggested. In this context, it is of special interest that the heterodimeric cytokine IL-23 can act on T cells and initiate the up-regulation of effector cytokines such as IL-17. To determine the role of this specific cytokine cascade for the induction of subsequently induced proinflammatory events we developed an in vitro system to investigate the IL-23-inducing capacity of Borrelia burgdorferi and the potential of the spirochete for inducing the IL-23/IL-17 axis. We used cells derived from mice deficient for IL-23 or IL-12 only or deficient for both IL-12 and IL-23 to define precisely the function of these cytokines. Experiments with bone marrow-derived dendritic cells (BMDC) identified these cells as sources for IL-23 but not for IL-12 after B. burgdorferi exposure. Subsequent investigations with T cell-depleted splenocyte fractions revealed a tight IL-23/IL-17 axis in response to the spirochetes. Monoclonal antibodies that block IL-23 showed further that BMDC-derived IL-23 was required for production of IL-17 in this experimental model. These in vitro data describing a spirochete-induced release of IL-23 may help to define IL-17-dependent inflammatory responses in the disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0928-8244
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
353-63
|
pubmed:meshHeading |
pubmed-meshheading:17378899-Animals,
pubmed-meshheading:17378899-Borrelia burgdorferi,
pubmed-meshheading:17378899-Cells, Cultured,
pubmed-meshheading:17378899-Dendritic Cells,
pubmed-meshheading:17378899-Interleukin-12,
pubmed-meshheading:17378899-Interleukin-17,
pubmed-meshheading:17378899-Interleukin-23,
pubmed-meshheading:17378899-Lymphocyte Depletion,
pubmed-meshheading:17378899-Mice,
pubmed-meshheading:17378899-Mice, Inbred C57BL,
pubmed-meshheading:17378899-Mice, Knockout,
pubmed-meshheading:17378899-T-Lymphocytes
|
pubmed:year |
2007
|
pubmed:articleTitle |
Borrelia burgdorferi potently activates bone marrow-derived conventional dendritic cells for production of IL-23 required for IL-17 release by T cells.
|
pubmed:affiliation |
Institute of Immunology, College of Veterinary Medicine, University of Leipzig, Leipzig, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|